These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 8690630

  • 1. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
    Wallgren A, Bernier J, Gelber RD, Goldhirsch A, Roncadin M, Joseph D, Castiglione-Gertsch M.
    Int J Radiat Oncol Biol Phys; 1996 Jul 01; 35(4):649-59. PubMed ID: 8690630
    [Abstract] [Full Text] [Related]

  • 2. Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.
    Karlsson P, Cole BF, Price KN, Gelber RD, Coates AS, Goldhirsch A, Castiglione M, Colleoni M, Gruber G, International Breast Cancer Study Group.
    Int J Radiat Oncol Biol Phys; 2016 Oct 01; 96(2):273-279. PubMed ID: 27598802
    [Abstract] [Full Text] [Related]

  • 3. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K.
    N Engl J Med; 1997 Oct 02; 337(14):949-55. PubMed ID: 9395428
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer.
    Lamb D, Atkinson C, Joseph D, O'Brien P, Ackland S, Bonaventura A, Dady P, Hamilton C, Spry N, Stewart J, Denham J.
    Australas Radiol; 1999 May 02; 43(2):220-6. PubMed ID: 10901906
    [Abstract] [Full Text] [Related]

  • 5. Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.
    International Breast Cancer Study Group (IBCSG).
    J Natl Cancer Inst; 2002 Jul 17; 94(14):1054-65. PubMed ID: 12122096
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.
    Griem KL, Henderson IC, Gelman R, Ascoli D, Silver B, Recht A, Goodman RL, Hellman S, Harris JR.
    J Clin Oncol; 1987 Oct 17; 5(10):1546-55. PubMed ID: 3309196
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):105-15. PubMed ID: 9747827
    [Abstract] [Full Text] [Related]

  • 15. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
    Ung O, Langlands AO, Barraclough B, Boyages J.
    J Clin Oncol; 1995 Feb 01; 13(2):435-43. PubMed ID: 7844606
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.
    Colleoni M, Litman HJ, Castiglione-Gertsch M, Sauerbrei W, Gelber RD, Bonetti M, Coates AS, Schumacher M, Bastert G, Rudenstam CM, Schmoor C, Lindtner J, Collins J, Thürlimann B, Holmberg SB, Crivellari D, Beyerle C, Neumann RL, Goldhirsch A, International Breast Cancer Study Group, German Breast Cancer Study Group.
    Br J Cancer; 2002 Jun 05; 86(11):1705-14. PubMed ID: 12087454
    [Abstract] [Full Text] [Related]

  • 19. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L, Cancer and Leukemia Group B.
    J Clin Oncol; 2003 May 01; 21(9):1825-35. PubMed ID: 12721260
    [Abstract] [Full Text] [Related]

  • 20. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
    Crivellari D, Bonetti M, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Thürlimann B, Price KN, Coates AS, Hürny C, Bernhard J, Lindtner J, Collins J, Senn HJ, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Goldhirsch A.
    J Clin Oncol; 2000 Apr 01; 18(7):1412-22. PubMed ID: 10735888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.